ALPHA IVF GROUP BERHAD
KLSE (MYR): ALPHA (0303)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.335
Today's Change
0.00 (0.00%)
Day's Change
0.33 - 0.335
Trading Volume
1,010,500
Financial
Market Cap
1,628 Million
NOSH
4,860 Million
Latest Quarter
31-Aug-2024 [#1]
Announcement Date
21-Oct-2024
Next Quarter
30-Nov-2024
Est. Ann. Date
18-Mar-2025
Est. Ann. Due Date
29-Jan-2025
QoQ | YoY
2.66% | 0.00%
Revenue | NP to SH
168,985.000 | 54,192.000
RPS | P/RPS
3.48 Cent | 9.63
EPS | P/E | EY
1.12 Cent | 30.04 | 3.33%
DPS | DY | Payout %
1.10 Cent | 3.28% | 98.43%
NAPS | P/NAPS
0.04 | 8.38
QoQ | YoY
36.12% | null%
NP Margin | ROE
32.84% | 27.88%
F.Y. | Ann. Date
31-Aug-2024 | 21-Oct-2024
Latest Audited Result
31-May-2024
Announcement Date
30-Sep-2024
Next Audited Result
31-May-2025
Est. Ann. Date
30-Sep-2025
Est. Ann. Due Date
27-Nov-2025
Revenue | NP to SH
167,586.000 | 52,933.000
RPS | P/RPS
3.45 Cent | 9.72
EPS | P/E | EY
1.15 Cent | 30.76 | 3.25%
DPS | DY | Payout %
0.70 Cent | 2.09% | 64.27%
NAPS | P/NAPS
0.04 | 8.38
YoY
null%
NP Margin | ROE
32.26% | 27.23%
F.Y. | Ann. Date
31-May-2024 | 17-Jul-2024
Revenue | NP to SH
171,980.000 | 57,524.000
RPS | P/RPS
3.54 Cent | 9.47
EPS | P/E | EY
1.20 Cent | 28.30 | 3.53%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
8.67% | null%
NP Margin | ROE
34.76% | 29.59%
F.Y. | Ann. Date
31-Aug-2024 | 21-Oct-2024
Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Date
Financial Result
Financial Ratio
Per Share Item
Performance
Valuation (End of Quarter)
Valuation (Ann. Date)
| Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Discussions
Be the first to like this. Showing 50 of 383 comments
Buying volume is healthy and momentum is good. Just wait for the upcoming soar 😌
2 weeks ago
Chill lah, ALPHA operates in a highly specialized field with stringent regulatory requirements, creating significant barriers to entry and protecting its market share. The potential return is promising, just the matter of time only.
2 weeks ago
ALPHA’s strategic presence in Malaysia, with proximity to key Asian markets, positions it to capitalize on the region’s growing demand for advanced reproductive healthcare.
2 weeks ago
Dividend is here - ALPHA IVF GROUP BERHAD declared Interim Dividend - RM 0.0050, the Ex Date on 17-Dec-2024.
2 weeks ago
No wonder directors have been buying a lot recently. I will continue to chip in to enjoy this dividend 😋
2 weeks ago
Constantly giving out dividend, will it attract more income investors and push the price up?
2 weeks ago
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3506133
The 0.5 sen per share interim dividend is a positive development for both shareholders and the company. This reflect the company's commitment to sharing profits with shareholders and signaling strong financial health
2 weeks ago
The worldwide fertility rates is declining, so they are perfectly positioned to capitalize on the increasing demand for IVF services. Much growth potential in this counter
2 weeks ago
Fib retracement at a nice zone and there is sign of divergence, good time to whack some.
2 weeks ago
ALPHA is killing it with all the latest tech in IVF treatments. They’re ahead of the game, which is a huge plus for investors.
1 week ago
From Aminvest -Retain BUY on Alpha IVF with unchanged FV of RM0.42, based on 28x CY25 PE. We attach a 3-star ESG rating to Alpha IVF. Our earnings forecast remains unchanged as the Group's 1QFY25 core net profit tracking expectation at 21.3% of our full year estimates.
1 week ago
ALPHA’s success rates in IVF are no joke among the industry players. Strong selling point for patients and investors like us.
1 week ago
They offers additional Assisted Reproductive Technology (ART) services too, such as ICSI, IUI, diagnostics, testing, screening procedures, and cryopreservation of eggs, sperm, and embryos.
1 week ago
Healthcare doesn’t slow down, even during tough times. ALPHA’s in a pretty safe spot, which is a huge bonus for long-term investors.
1 week ago
ALPHA is slowly becoming a recognized name, not just locally but internationally. That kind of growth potential is exciting.
1 week ago
+1 here. I will slowly build up my Alpha stock position
NorAfan
Masuk lagi semasa dapat dividen pd 31 Dec 🙂
2 days ago
1 week ago
Keep top up Alpha, where the comapny has a dividend policy which plans to pay out a minimum of 60% of its earnings as dividends, translating to a 2.3% dividend yield in FY24.
1 week ago
The fertility industry is growing like crazy worldwide, and ALPHA is positioned to grab a nice slice of that pie.
1 week ago
There is a bright future in expanding the markets in China, Indonesia and the Philippines 👍
6 days ago
ALPHA isn’t just serving Malaysia anymore, they’re steadily building a name across Southeast Asia. Big growth potential here
5 days ago
ALPHA will be the SEA regional leader in fertility care with more expansion into Indonesia and the Philippines, stay for the long term growth & dividend
4 days ago
They’ve got some of the most advanced tech in IVF treatments. That edge keeps them ahead of competitors.
4 days ago
With fertility awareness growing in underdeveloped regions, ALPHA has the opportunity to be a pioneer in those markets.
3 days ago
Not only that, genetic testing is becoming more popular in IVF, their expertise in this area will definitely drive future growth.
2 days ago
NOSH is too high in the market! For it to move, it really needs a very high volume trade. DY will be low too, unless the revenue and margin grow significantly.
2 days ago
YTL Power's NOSH is also high. We just need to wait for ALPHA's turn to be goreng up 😁
2 days ago
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
Stock Market Enthusiast
Top 3 AI/Data Center Newsflow for the 3rd Week of December - #TENAGA, #YTL, #YTLPOWER
2
Rakuten Trade Research Reports
3
save malaysia!
4
Good Articles to Share
5
Good Articles to Share
Honda and Nissan consider mutual production of vehicles, Kyodo reports
6
Good Articles to Share
World’s largest stablecoin issuer Tether sees US$10b in net profits for 2024
7
Good Articles to Share
8
Good Articles to Share
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
sweetpie
ALPHA collaborates with international experts and institutions, bringing global best practices to their patients. This makes them a trusted name in the field of reproductive medicine.
3 weeks ago